Sector revisions Immatics N.V.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-02 EDT			5-day change	1st Jan Change
7.590 ^USD	-10.07%		-9.32%	-27.71%

10-02	Nanobiotix Names New Finance Chief	MT
10-01	Nanobiotix Appoints Arnd Christ as CFO	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
IMMATICS N.V.		6
WUXI APPTEC CO., LTD.		18
ARGENX SE		15
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		22
IQVIA HOLDINGS INC.		19
BEONE MEDICINES AG		28
CELLTRION, INC.		22
WUXI BIOLOGICS (CAYMAN) INC.		24
BIONTECH SE		20
INSMED INCORPORATED		23
GENMAB A/S		15
MEDPACE HOLDINGS, INC.		13
PHARMAESSENTIA CORPORATION		8
ASCENDIS PHARMA A/S	-	20
EUROFINS SCIENTIFIC SE		14
EXELIXIS, INC.		15
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.		19
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		15
TEMPUS AI, INC.		18
Average		18
Weighted average by Cap.		19